RLWM
RF&L Wealth Management Portfolio holdings
AUM
$155M
This Quarter Return
+6.37%
1 Year Return
+14.13%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$141M
AUM Growth
+$141M
(+7.5%)
Cap. Flow
+$1.56M
Cap. Flow
% of AUM
1.1%
Top 10 Holdings %
Top 10 Hldgs %
55.41%
Holding
59
New
3
Increased
13
Reduced
20
Closed
1
Top Buys
| 1 |
CrowdStrike
CRWD
|
$982K |
| 2 |
Vanguard Short-Term Bond ETF
BSV
|
$427K |
| 3 |
Merck
MRK
|
$329K |
| 4 |
NVIDIA
NVDA
|
$259K |
| 5 |
Pfizer
PFE
|
$206K |
Top Sells
| 1 |
Dimensional US Marketwide Value ETF
DFUV
|
$253K |
| 2 |
Procter & Gamble
PG
|
$218K |
| 3 |
Dimensional US Targeted Value ETF
DFAT
|
$136K |
| 4 |
Exxon Mobil
XOM
|
$120K |
| 5 |
Vanguard Total Stock Market ETF
VTI
|
$49.6K |
Sector Composition
| 1 | Technology | 10.62% |
| 2 | Healthcare | 6.23% |
| 3 | Consumer Staples | 3.72% |
| 4 | Consumer Discretionary | 3.59% |
| 5 | Communication Services | 2.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Vanguard Intermediate-Term Bond ETF
BIV
$24B
| $292K | 0.21% |
3,725
-250
| -6% | -$19.6K |
|
52
Vanguard Mega Cap Growth ETF
MGK
$28.6B
| $275K | 0.19% |
855
| – | – |
|
53
Chevron
CVX
$326B
| $254K | 0.18% |
1,725
| – | – |
|
|
RVNC
54
DELISTED
Revance Therapeutics, Inc.
RVNC
| $249K | 0.18% |
48,000
| – | – |
|
55
Xtrackers S&P 500 ESG ETF
SNPE
$2.06B
| $247K | 0.17% |
4,697
| – | – |
|
56
Alphabet (Google) Class A
GOOGL
$2.56T
| $236K | 0.17% |
1,423
| – | – |
|
57
First Trust Technology AlphaDEX Fund
FXL
$1.34B
| $225K | 0.16% |
1,625
| – | – |
|
|
58
Pfizer
PFE
$142B
| $206K | 0.15% |
+7,120
| New | +$206K |
|
|
59
Procter & Gamble
PG
$370B
| – | – |
-1,322
| Closed | -$218K |
|